These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25385879)

  • 1. Obesity-related hypertension: possible pathophysiological mechanisms.
    Vaněčková I; Maletínská L; Behuliak M; Nagelová V; Zicha J; Kuneš J
    J Endocrinol; 2014 Dec; 223(3):R63-78. PubMed ID: 25385879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical developmental periods in the pathogenesis of hypertension.
    Kuneš J; Kadlecová M; Vaněčková I; Zicha J
    Physiol Res; 2012; 61(Suppl 1):S9-17. PubMed ID: 22827878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity.
    Gilardini L; Parati G; Sartorio A; Mazzilli G; Pontiggia B; Invitti C
    J Hum Hypertens; 2008 Feb; 22(2):75-82. PubMed ID: 17882228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of obesity-induced hypertension.
    Kotsis V; Stabouli S; Papakatsika S; Rizos Z; Parati G
    Hypertens Res; 2010 May; 33(5):386-93. PubMed ID: 20442753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
    Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome.
    Seravalle G; Grassi G
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):175-9. PubMed ID: 26942609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management.
    Kotchen TA
    Am J Hypertens; 2010 Nov; 23(11):1170-8. PubMed ID: 20706196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of aldosterone with obesity-related hypertension and the metabolic syndrome.
    Vogt B; Bochud M; Burnier M
    Semin Nephrol; 2007 Sep; 27(5):529-37. PubMed ID: 17868790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome.
    Grassi G
    Hypertens Res; 2006 Nov; 29(11):839-47. PubMed ID: 17345783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
    Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.
    da Silva AA; do Carmo JM; Li X; Wang Z; Mouton AJ; Hall JE
    Can J Cardiol; 2020 May; 36(5):671-682. PubMed ID: 32389340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension as part of the metabolic syndrome.
    Cheung B
    J Hum Hypertens; 2008 Dec; 22(12):871-4. PubMed ID: 18548089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of abnormal renal sodium handling in obesity hypertension.
    Hall JE
    Am J Hypertens; 1997 May; 10(5 Pt 2):49S-55S. PubMed ID: 9160781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension in obese patients: a dysmetabolic hypertension with a possible adipocyte dysfunction mechanism.
    Blaj S; Stanciu S; Jurcut C; Ciobîcă L
    Rom J Intern Med; 2003; 41(2):103-11. PubMed ID: 15526495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of obesity-related hypertension.
    Lamounier-Zepter V; Bornstein SR; Ehrhart-Bornstein M
    Horm Metab Res; 2004 Jun; 36(6):376-80. PubMed ID: 15241727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the sympathetic nervous system in obesity-related hypertension.
    da Silva AA; do Carmo J; Dubinion J; Hall JE
    Curr Hypertens Rep; 2009 Jun; 11(3):206-11. PubMed ID: 19442330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
    Lastra G; Manrique C; Sowers JR
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.